The Algae That Finally Learned to Taste Good: Inside Edonia's €15M Bet on Spirulina Protein

For decades, spirulina has been the food that almost everyone respected and almost nobody enjoyed. The blue-green microalgae is one of the oldest living organisms on Earth, and it is undeniably nutritious. It has also, for most of its career in the wellness industry, tasted like the bottom of a pond.

This week, a Paris startup asked investors to bet €15 million that this particular problem is now solved. On October 6, Edonia announced a €15 million funding round (about $16.8 million) to industrialize its flagship ingredient, Edo: a tender, savory, brown mince made from spirulina that the company says eats like a protein filling rather than a supplement. The round was led by SWEN Blue Ocean 2, Asterion Ventures, and EIT Food, the EU-backed accelerator, alongside non-dilutive funding from France's state-owned bank Bpifrance under the France 2030 initiative and additional bank loans.

A €15 million bet on an ancient organism

Edonia was founded in 2023 by Hugo Valentin, Pierre Mignon, and Nicolas Irlinger, and the thesis is disarmingly simple. Rather than engineering a new protein from scratch, the company takes one of the most protein-dense organisms in nature and fixes its single worst attribute: the taste. The company's answer to spirulina's sensory problem is a proprietary, patented process it calls Edonization, developed with the research laboratory of AgroParisTech, one of France's leading agronomy schools.

The process involves cooking spirulina in oil at a precise temperature, which changes its color, flavor, and texture. Out comes a fluffy grain with a natural umami character and none of the off-notes that have kept algae out of mainstream recipes for half a century. The ingredient list is two items long: spirulina and oil. No texturizing agents, no added flavors, no extrusion, no fermentation, no enzymatic treatments. In an industry where plant-based products often read like chemistry experiments, that short label is the whole pitch.

The numbers on the spec sheet are serious. Edo contains 27 grams of protein per 100 grams, roughly matching beef, with all essential amino acids and a PDCAAS protein-quality score of 0.97, close to the theoretical maximum of 1.0. It carries 20 milligrams of bioavailable iron per 100 grams, higher than beef or soy according to the company. And its climate footprint is 1.95 kilograms of CO2 equivalent per unit of protein, which Edonia says is 27 times lower than beef and 2.5 times lower than soy mince.

Why investors are listening now

The timing matters, because the alternative protein industry is not where it expected to be. Industry reporting citing Good Food Institute data puts venture funding for alternative proteins at €306 million in the first half of 2026, down from €341 million a year earlier, with capital consolidating around fewer, larger rounds. Within that shrinking total, precision fermentation companies raised €100 million, already more than the whole category raised in 2025, while biomass fermentation grew from €60 million to €99 million. Bain & Company's Green Technology Performance Index, which measures technologies against projections made in 2015, ranks alternative proteins among the categories that have most underperformed expectations. Beyond Meat has changed product formats and its brand identity to chase growth; Oatly's market capitalization has fallen more than 96 percent in five years.

The industry's own diagnosis, echoed by Bain's sustainability practice, is that the consumer proposition was never strong enough: taste, texture, and price did not carry the products into daily habits. Edonia's response is not to build a better beef replica. It is to stop imitating altogether. The company markets Edo as a standalone protein for stuffed tomatoes, ravioli, curries, salads, pies, and soups. The bet is that consumers who rejected ultra-processed meat mimics will accept an honest, minimally processed ingredient with a clean label.

We've proven that a whole food protein can outperform the animal on nutrition and compete on price, at real volume, with real clients.

Hugo Valentin, Edonia's co-founder and CEO, has been making the case that the pilot phase is over. The company says it has secured €30 million in pre-orders through around twenty contracts with leading industry players, an unusually large demand book for a startup of this size. Global catering group Newrest, which operates in 50 countries, began serving Edo in 2025 and now puts thousands of meals containing the ingredient on plates each month across its French catering sites. In retail, French nutrition company Aliive put Edo into two ready meals sold under its Dietbon weight-management line, and reported that 40 percent of consumers switched from the meat versions to the spirulina versions, with matching satisfaction scores.

The industrial test ahead

The €15 million is earmarked for the moment every food-tech startup either survives or dies: the move from pilot to industrial scale. Edonia industrialized its technology in 2024 with a €2 million round that funded a functional pilot plant in Agen, in southwestern France. The new capital will open a full industrial-scale plant inside an existing facility owned by Maison Chancerelle, a canned tuna producer in Brittany, with the plant expected to open within a year.

From there, the company plans to expand its B2B foodservice model across Europe, Japan, and the United States. Scaling a process that currently works at pilot level is a genuine engineering challenge, and food manufacturing is littered with companies that proved the chemistry and failed the logistics. Edonia's €30 million in pre-orders gives it something most of those companies lacked: a demand signal strong enough to justify the capital expenditure before the first industrial batch ships.

Technology, in perspective

There is a useful lesson buried in this funding round, and it is not really about algae. The first wave of alternative protein assumed the problem was mimicry: if engineers could replicate the texture of a burger, consumers would follow. A decade of funding, roughly $20 billion by some estimates, produced products that were often expensive, heavily processed, and stocked in a shrinking corner of the supermarket. Edonia belongs to a second wave that has internalized the failure. Its ingredient does not pretend to be meat. It is not built in a bioreactor or assembled from isolates. It is cooked, in oil, at a controlled temperature, in a process developed with a public agricultural university.

That simplicity is also a hedge against the sector's biggest open question: who pays for the factories. Shared and repurposed infrastructure, like the Brittany plant, and pre-sold production, like the €30 million order book, are how a capital-constrained industry might actually get built. Spirulina spent fifty years as a punchline about pond scum and wellness powders. Whether it spends the next fifty as dinner depends less on the organism than on the manufacturing. For once, a food-tech company seems to know that.